Intellia Therapeutics, Inc. (NTLA) Q2 2026 Earnings Call Transcript
1 source
·1d ago
← All stories
Intellia Therapeutics
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.
- HQ
- CAMBRIDGE, MA
- Industry
- In Vitro & In Vivo Diagnostic Substances
- Country
- US
- Founded
- 2014
- Website
- intelliatx.com
In the news · 1
More in Healthcare